<DOC>
	<DOCNO>NCT00569374</DOCNO>
	<brief_summary>This 7 week , open-label pilot clinical trial examine safety tolerability modafinil 400mg/day potential treatment reduce methamphetamine use methamphetamine-dependent volunteer .</brief_summary>
	<brief_title>Safety Tolerability Modafinil Methamphetamine Dependence</brief_title>
	<detailed_description />
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>1865 year old currently enrol treatment program subject must history methamphetamine use recent use confirm positive urine toxicology screen amphetamine month prior study entry subject must meet DSMIV criterion amphetamine dependence assess substance abuse section Structured Clinical Interview DSMIV ( SCID ) woman childbearing age must negative pregnancy test enroll study , agree monthly pregnancy testing , agree use appropriate form birth control duration study current diagnosis alcohol , opiate , sedative physical dependence ill health ( e.g. , major cardiovascular , renal , endocrine , hepatic disorder ) history schizophrenia , bipolar type I disorder present recent use overthecounter prescription psychoactive drug drug ( ) would expect major interaction drug test medical contraindication receive study medication ( e.g. , allergy modafinil , treatment cyclosporine , clomipramine , desipramine ) Current suicidality psychosis liver function test ( i.e. , liver enzymes ) great three time normal level pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>